Erlotinib - PDFSEARCH.IO - Document Search Engine

Erlotinib
Results: 189

#	Item
71	Public Summary Document Application No. 1161 – Gefitinib first line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC) Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:55 Quinazolines Organofluorides Amines Organochlorides Lung cancer Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
72	Public Summary Document Application No. 1173 – Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for erlotinib treatment as a first line therapy in patients with locally advanced or metastat Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:43 Amines Quinazolines Lung cancer Organofluorides Alkynes Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Medicine Organic chemistry
73	MSAC Application 1161: Final Decision Analytic Protocol (DAP) to guide the assessment of testing for mutations in the epidermal growth factor receptor (EGFR) gene in patients with locally advanced or metastatic non small Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:56 Amines Quinazolines Lung cancer Organofluorides Gefitinib Morpholines Epidermal growth factor receptor Erlotinib Non-small-cell lung carcinoma Chemistry Medicine Organic chemistry
74	Medical Services Advisory Committee Public Summary Document Reference No. 41 – Epidermal Growth Factor Receptor Gene Testing and Access to PBS listed Gefitinib Sponsors: Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2013-11-01 01:30:18 Amines Quinazolines Tyrosine kinase receptors Lung cancer Organofluorides Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Biology
75	Public Summary Document Application No. 1293 – Epidermal Growth Factor Receptor (EGFR) testing to determine eligibility for afatinib treatment in patients with locally advanced or metastatic non-small-cell lung cancer Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:26 Quinazolines Organofluorides Amines Organochlorides Lung cancer Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
76	Public Summary Document Application No. 1293 – Epidermal Growth Factor Receptor (EGFR) testing to determine eligibility for afatinib treatment in patients with locally advanced or metastatic non-small-cell lung cancer Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:25 Quinazolines Organofluorides Amines Lung cancer Organochlorides Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
77	Public Summary Document Application No. 1173 – Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for a Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:41 Quinazolines Amines Organofluorides Lung cancer Organochlorides Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
78	Application 1161: Consultation Decision Analytic Protocol (DAP) to guide the assessment of testing for mutations in the epidermal growth factor receptor (EGFR) gene in patients with locally Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:56 Amines Quinazolines Lung cancer AstraZeneca Gefitinib Morpholines Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
79	MSAC Application 1173: Final Decision Analytical Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for erlotinib treatment as a first-line therapy in Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:40 Lung cancer Amines Quinazolines Organofluorides Alkynes Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Medicine Chemistry Oncology
80	Application 1161: Consultation Decision Analytic Protocol (DAP) to guide the assessment of testing for mutations in the epidermal growth factor receptor (EGFR) gene in patients with locally advanced or metastatic non sma Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:55 Amines Quinazolines Lung cancer Organofluorides Gefitinib Morpholines Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine

UPDATE